Holen Sie sich die Stockscreener-App
2.00
0.99%
-0.02
Handel nachbörslich:
2.04
0.04
+2.00%
Schlusskurs vom Vortag:
$2.02
Offen:
$1.97
24-Stunden-Volumen:
21,012
Relative Volume:
0.53
Marktkapitalisierung:
$8.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-0.0149
EPS:
-134.6096
Netto-Cashflow:
$-9.67M
1W Leistung:
+1.01%
1M Leistung:
-2.91%
6M Leistung:
-49.62%
1J Leistung:
-73.68%
1-Tages-Spanne:
$1.97
$2.04
1-Wochen-Bereich:
$1.9543
$2.08
52-Wochen-Spanne:
$1.33
$40.00
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
2.00 | 8.41M | 0 | -38.99M | -9.67M | -134.61 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-03-03 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-10-22 | Eingeleitet | Truist | Buy |
| 2020-07-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-23 | Eingeleitet | Citigroup | Buy |
| 2017-10-23 | Eingeleitet | Jefferies | Buy |
| 2017-10-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Nucana Plc Adr Aktie (NCNA) Neueste Nachrichten
Buying pressure lifts NuCana stock higher in today's trading - Traders Union
NCNA Stock Chart | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana shares dip amid rising selling pressure - Traders Union
NuCana stock climbs 3.03% as price holds in tight $2.00–$2.08 range - Traders Union
NuCana shares jump as stock buying pressure builds - Traders Union
NuCana stock price forecast: $2.31 resistance as NCNA posts 10.10% gain - Traders Union
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update - ChartMill
What triggered NuCana shares' latest price surge - Traders Union
+3.23% for NuCana stock as price rebounds after pronounced underperformance - Traders Union
What is behind NuCana stock's recent drop in value today - Traders Union
NuCana publishes 2025 annual report and schedules annual general meeting - Investing.com
NuCana (NASDAQ: NCNA) outlines 2025 loss, cash runway and key 2026 AGM capital votes - Stock Titan
NuCana stock price forecast: $1.83 support in focus as NCNA drops 3.17% - Traders Union
NCNA News | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana stock price forecast: $2.25 resistance as NCNA gains 3.92% - Traders Union
Stuck in a narrow $2.02–$2.30 range lifts NuCana stock 4.31% - Traders Union
Unusual Machines, NuCana, Navigator Holdings and other big stocks moving lower in Friday's pre-market session - MSN
NuCana stock price forecast: $2.41 resistance eyed as NCNA moves down 4.37% - Traders Union
Overbought levels pause NuCana stock advance near recent highs - Traders Union
+5.10% for NuCana stock as overbought conditions emerge - Traders Union
+8.63% for NuCana stock as fresh highs prompt overbought signals - Traders Union
NuCana stock price forecast: $2.05–$2.40 range as NCNA gains 18.42% - Traders Union
-6.83% for NuCana stock as tight trading range restricts moves - Traders Union
NuCana stock rises after bouncing from $1.60 support - Traders Union
NuCana plc Stock: Prodrug Technology Platform Targets Oncology Challenges for Long-Term Investor Val - AD HOC NEWS
Bearish signals and low breakout odds keep NuCana stock near resistance - Traders Union
NuCana plc Stock: Clinical-Stage Biotech Innovating Cancer Therapies with ProTide Technology - AD HOC NEWS
-3.18% for NuCana stock as price stays pinned below key support levels - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Negative indicators push NuCana stock lower amid continued selling activity - Traders Union
Selling pressure pushes NuCana stock lower in today's trading - Traders Union
What is behind NuCana stock's recent gain in value today - Traders Union
Technical weakness and oversold signals: NuCana stock falls 3.22% - Traders Union
NuCana shares see a dip: what is pressuring the stock - Traders Union
Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NuCana (NASDAQ: NCNA) outlines 2025 losses, cash and oncology pipeline risks - Stock Titan
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update - ChartMill
Finanzdaten der Nucana Plc Adr-Aktie (NCNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):